UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000033794
Receipt number R000037955
Scientific Title Phase II study of Nivolumab in patients with relapsed/refractory hematologic malignancies
Date of disclosure of the study information 2018/09/01
Last modified on 2023/06/16 06:50:15

No. Disposal Last modified on Item of update
1 Insert 2018/08/17 14:38:44
2 Update 2018/09/19 08:36:17 Recruitment status
3 Update 2018/10/05 11:00:26 UMIN ID1
4 Update 2019/02/22 08:51:14 Institutions
5 Update 2020/03/18 11:32:35 Key inclusion criteria
Key inclusion criteria
6 Update 2020/03/18 12:11:32 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address


Zip code
Address
Name of primary person or sponsor
Institute
Organization
Nationality of Funding Organization
Nationality of Funding Organization
Address1
Organization
Organization
Address
Address
Tel
Email
Institutions
7 Update 2020/03/18 12:15:34 Date of IRB
Last follow-up date
8 Update 2023/06/16 06:50:15 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete